PPH vs. NLR
PPH (VanEck Vectors Pharmaceutical ETF) and NLR (VanEck Uranium and Nuclear ETF) are both exchange-traded funds - PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index, while NLR is a Alternative Energy Equities fund tracking the MVIS Global Uranium & Nuclear Energy Index. Both are passively managed. Over the past 10 years, PPH returned 7.46%/yr vs 13.66%/yr for NLR. At a 0.42 correlation, their price movements are largely independent. PPH charges 0.36%/yr vs 0.56%/yr for NLR.
Performance
PPH vs. NLR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PPH achieves a -0.76% return, which is significantly lower than NLR's 6.14% return. Over the past 10 years, PPH has underperformed NLR with an annualized return of 7.46%, while NLR has yielded a comparatively higher 13.66% annualized return.
PPH
- 1D
- 0.33%
- 1M
- -0.56%
- YTD
- -0.76%
- 6M
- 2.14%
- 1Y
- 17.87%
- 3Y*
- 12.03%
- 5Y*
- 9.22%
- 10Y*
- 7.46%
NLR
- 1D
- -4.59%
- 1M
- -8.11%
- YTD
- 6.14%
- 6M
- 1.51%
- 1Y
- 36.84%
- 3Y*
- 35.11%
- 5Y*
- 21.94%
- 10Y*
- 13.66%
PPH vs. NLR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Vectors Pharmaceutical ETF | -0.76% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
NLR VanEck Uranium and Nuclear ETF | 6.14% | 56.50% | 14.26% | 36.67% | 2.29% | 13.63% | 3.49% | 0.20% | 4.94% | 8.25% |
Correlation
The correlation between PPH and NLR is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Aug 16, 2007 | 0.42 |
Over the past year, the correlation between PPH and NLR has dropped to 0.06 - well below their long-term average of 0.42, suggesting their price drivers have been diverging.
PPH vs. NLR - Sectors Allocation Comparison
Sectors
PPH
NLR
Healthcare
-
Industrials
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
PPH
NLR
-
Industrials
PPH
NLR
Basic Materials
PPH
-
NLR
-
Communication Services
PPH
-
NLR
-
Consumer Cyclical
PPH
-
NLR
-
Consumer Defensive
PPH
-
NLR
-
Energy
PPH
-
NLR
Financial Services
PPH
-
NLR
-
Real Estate
PPH
-
NLR
-
Technology
PPH
-
NLR
Utilities
PPH
-
NLR
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. NLR — Risk / Return Rank
PPH
NLR
PPH vs. NLR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and VanEck Uranium and Nuclear ETF (NLR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PPH | NLR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.17 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.17 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 1.43 | +0.23 |
| Martin ratioReturn relative to average drawdown | 3.88 | 2.93 | +0.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PPH | NLR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.04 | 0.88 | +0.17 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.61 | 0.75 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.57 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.18 | +0.12 |
Drawdowns
PPH vs. NLR - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, smaller than the maximum NLR drawdown of -65.05%. Use the drawdown chart below to compare losses from any high point for PPH and NLR.
Loading charts...
Drawdown Indicators
| PPH | NLR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -65.05% | +13.60% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -25.80% | +15.04% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | -30.48% | +12.42% |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | -30.48% | +10.22% |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | -34.35% | +4.65% |
Current DrawdownCurrent decline from peak | -8.34% | -19.80% | +11.46% |
Average DrawdownAverage peak-to-trough decline | -17.31% | -35.72% | +18.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.61% | 12.61% | -8.00% |
Volatility
PPH vs. NLR - Volatility Comparison
The current volatility for VanEck Vectors Pharmaceutical ETF (PPH) is 4.73%, while VanEck Uranium and Nuclear ETF (NLR) has a volatility of 13.18%. This indicates that PPH experiences smaller price fluctuations and is considered to be less risky than NLR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | NLR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.73% | 13.18% | -8.45% |
Volatility (6M)Calculated over the trailing 6-month period | 11.67% | 32.83% | -21.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.26% | 42.32% | -25.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.07% | 29.24% | -14.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.96% | 24.02% | -7.06% |
PPH vs. NLR - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is lower than NLR's 0.56% expense ratio.
Dividends
PPH vs. NLR - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.12%, less than NLR's 2.40% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NLR VanEck Uranium and Nuclear ETF | 2.40% | 2.55% | 0.76% | 4.54% | 2.02% | 1.99% | 2.23% | 2.21% | 3.91% | 4.86% | 3.62% | 3.30% |
PPH VanEck Vectors Pharmaceutical ETF | 2.12% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
PPH and NLR have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NLR has higher volatility (13.18%) compared to PPH (4.73%). In terms of maximum drawdown, PPH dropped -51.45% vs NLR's -65.05%.
On 10-year performance, NLR leads with 13.66% vs 7.46% for PPH. On fees, PPH is cheaper at 0.36% per year. On volatility, PPH has been the lower-risk option at 4.73%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, NLR has performed better with a 13.66% return vs 7.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.56% for NLR.
NLR has the higher dividend yield at 2.40%, compared with 2.12% for PPH.
PPH is categorized as Health & Biotech Equities, while NLR is Alternative Energy Equities. PPH tracks MVIS US Listed Pharmaceutical 25 Index, while NLR tracks MVIS Global Uranium & Nuclear Energy Index. Their fees differ too: 0.36% for PPH and 0.56% for NLR.
PPH currently has the higher Sharpe Ratio (1.04 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PPH and NLR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer